相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive assessment of automatic structural alignment against a manual standard, the scop classification of proteins
Mark Gerstein et al.
PROTEIN SCIENCE (2010)
Structural Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804
Li Xing et al.
BIOCHEMISTRY (2009)
Structure-Based Optimization of Potent and Selective Inhibitors of the Tyrosine Kinase Erythropoietin Producing Human Hepatocellular Carcinoma Receptor B4 (EphB4)
Karine Lafleur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies
Jack A. Bikker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Inhibitors of the tyrosine kinase EphB4.: Part 1:: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
Catherine Bardelle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The clinical implications of sunitinib-induced hypothyroidism:: a prospective evaluation
P. Wolter et al.
BRITISH JOURNAL OF CANCER (2008)
Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug Discovery
Paul Bamborough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, synthesis, and biological evaluation of novel tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: Focus on optimized interactions with the enzyme's surface-exposed front region
Stefan A. Laufer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
High-throughput kinase profiling as a platform for drug discovery
David M. Goldstein et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Structure-based tailoring of compound libraries for high-throughput screening: Discovery of novel EphB4 kinase inhibitors
Peter Kolb et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Oleg Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Substrate and docking interactions in serine/threonine protein kinases
Elizabeth J. Goldsmith et al.
CHEMICAL REVIEWS (2007)
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding
Marie A. Bogoyevitch et al.
DRUG DISCOVERY TODAY (2007)
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics
Jimmy A. Blair et al.
NATURE CHEMICAL BIOLOGY (2007)
Molecular basis for specificity in the druggable kinome: sequence-based analysis
Jianping Chen et al.
BIOINFORMATICS (2007)
Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors
Jeffrey Jie-Lou Liao
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Rational design of inhibitors that bind to inactive kinase conformations
Y Liu et al.
NATURE CHEMICAL BIOLOGY (2006)
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors:: Protein structure-guided design and SAR
CM Richardson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity
M Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3
BM Swahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding
FB Sheinerman et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Kinomics: Characterizing the therapeutically validated kinase space
M Vieth et al.
DRUG DISCOVERY TODAY (2005)
Features of selective kinase inhibitors
ZA Knight et al.
CHEMISTRY & BIOLOGY (2005)
Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate
CW Yde et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets
M Vieth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
RM Biondi
TRENDS IN BIOCHEMICAL SCIENCES (2004)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Opinion - Switching on kinases: oncogenic activation of BRAF and the PDGFR family
NJ Dibb et al.
NATURE REVIEWS CANCER (2004)
Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
CE Fitzgerald et al.
NATURE STRUCTURAL BIOLOGY (2003)
Specific targeted therapy of chronic myelogenous leukemia with imatinib
MWN Deininger et al.
PHARMACOLOGICAL REVIEWS (2003)
The structure of JNK3 in complex with small molecule inhibitors: Structural basis for potency and selectivity
G Scapin et al.
CHEMISTRY & BIOLOGY (2003)
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors
S Blencke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2
R Battistutta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Tyrosine kinase inhibitors.: 17.: Irreversible inhibitors of the epidermal growth factor receptor:: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions
JB Smaill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Combinatorial chemoprevention of intestinal neoplasia
CJ Torrance et al.
NATURE MEDICINE (2000)
分享论文
